Skip to main content

Kenneth T. Mills

Equibles does not estimate personal net worth.

Get an email with a short summary when REGENXBIO Inc. publishes a filing, an earnings call transcript or a press release.

Get RGNX alerts

About Kenneth T. Mills

Kenneth T. Mills is recorded as Chairman at REGENXBIO Inc. (RGNX) since June 13, 2024. REGENXBIO Inc. reported in an 8-K filed October 16, 2026 that Kenneth T. Mills resigned as board of directors, effective October 21, 2026. The same filing states: “Mr. Mills’ decision was not related to any disagreement with the Company on any matter relating to its operations, policies, or practices.” REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Kenneth T. Mills was appointed Chairman of the Board. The proxy statement of REGENXBIO Inc. reports total compensation of $5,507,038 for Kenneth T. Mills in fiscal 2024, including a base salary of $340,998. Disclosed compensation is on record for 7 fiscal years. REGENXBIO Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at REGENXBIO Inc. includes Curran M. Simpson (CEO, COO and Board Member), Allan M. Fox (Chairman and Board Member), George Migausky (Chairman and Board Member) and 7 others.

“On October 14, 2026, Kenneth T. Mills resigned from the board of directors (the "Board") of REGENXBIO Inc. (the "Company") effective October 21, 2026.”
“Mr. Mills’ decision was not related to any disagreement with the Company on any matter relating to its operations, policies, or practices.”
REGENXBIO Inc. Form 8-K, filed October 16, 2026 · Read the filing
“Mr. Mills will continue to serve as a director and has been named Chairman of the Board.”
REGENXBIO Inc. Form 8-K, filed June 13, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Chairman

2009-01-01–present

Leadership on record at REGENXBIO Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 REGENXBIO Inc. (RGNX) $340,998 $5,507,038
2023 REGENXBIO Inc. (RGNX) $676,790 $5,916,713
2022 REGENXBIO Inc. (RGNX) $650,759 $5,753,713
2021 REGENXBIO Inc. (RGNX) $631,805 $8,622,941
2020 REGENXBIO Inc. (RGNX) $613,403 $7,644,087
2019 REGENXBIO Inc. (RGNX) $595,537 $6,147,269
2018 REGENXBIO Inc. (RGNX) $546,364 $4,938,199

Recent activity